60 related articles for article (PubMed ID: 35763110)
1. N
Xu K; Dai X; Wu J; Wen K
J Cancer Res Clin Oncol; 2022 Dec; 148(12):3375-3384. PubMed ID: 35763110
[TBL] [Abstract][Full Text] [Related]
2. CLSPN actives Wnt/β-catenin signaling to facilitate glycolysis and cell proliferation in oral squamous cell carcinoma.
Hou Z; Wu C; Tang J; Liu S; Li L
Exp Cell Res; 2024 Feb; 435(2):113935. PubMed ID: 38237848
[TBL] [Abstract][Full Text] [Related]
3. TIMELESS promotes reprogramming of glucose metabolism in oral squamous cell carcinoma.
Chen Y; Han Z; Zhang L; Gao C; Wei J; Yang X; Han Y; Li Y; Zhang C; Wei Y; Dong J; Xun W; Sun W; Zhang T; Zhang H; Chen J; Yuan P
J Transl Med; 2024 Jan; 22(1):21. PubMed ID: 38178094
[TBL] [Abstract][Full Text] [Related]
4. The m6A reader IGF2BP2 promotes the progression of esophageal squamous cell carcinoma cells by increasing the stability of OCT4 mRNA.
Zhao R; Li T; Zhao X; Yang Z; Ma L; Wang X
Biochem Cell Biol; 2024 Apr; 102(2):169-178. PubMed ID: 37917979
[TBL] [Abstract][Full Text] [Related]
5. IGF2BP2 promotes cell invasion and epithelial-mesenchymal transition through Src-mediated upregulation of EREG in oral cancer.
Lin CW; Yang WE; Su CW; Lu HJ; Su SC; Yang SF
Int J Biol Sci; 2024; 20(3):818-830. PubMed ID: 38250159
[TBL] [Abstract][Full Text] [Related]
6. DDX27 regulates oral squamous cell carcinoma development through targeting CSE1L.
Li G; Li R; Wang W; Sun M; Wang X
Life Sci; 2024 Mar; 340():122479. PubMed ID: 38301874
[TBL] [Abstract][Full Text] [Related]
7. KLF7 regulates super-enhancer-driven IGF2BP2 overexpression to promote the progression of head and neck squamous cell carcinoma.
Cai H; Liang J; Jiang Y; Wang Z; Li H; Wang W; Wang C; Hou J
J Exp Clin Cancer Res; 2024 Mar; 43(1):69. PubMed ID: 38443991
[TBL] [Abstract][Full Text] [Related]
8. Knockdown of RNA-binding protein IMP3 suppresses oral squamous cell carcinoma proliferation by destabilizing E2F5 transcript.
Wang Z; Zhang H; Li F; Huang C
Aging (Albany NY); 2024 Jan; 16(2):1897-1910. PubMed ID: 38271139
[TBL] [Abstract][Full Text] [Related]
9. AKR1B10 accelerates glycolysis through binding HK2 to promote the malignant progression of oral squamous cell carcinoma.
Cai Y; Li H; Xie D; Zhu Y
Discov Oncol; 2024 Apr; 15(1):132. PubMed ID: 38671310
[TBL] [Abstract][Full Text] [Related]
10. N
Yu H; Zhao K; Zeng H; Li Z; Chen K; Zhang Z; Li E; Wu Z
Biomed Pharmacother; 2021 Jan; 133():111075. PubMed ID: 33378974
[TBL] [Abstract][Full Text] [Related]
11. Bioinformatics analysis of the prognosis and biological significance of N6 methyladenine regulators in oral squamous cell carcinoma.
Yu M; Shen F; Li X; Zhu C; Pei Y; Zhang M; Xiao W
J Gene Med; 2024 Jan; 26(1):e3619. PubMed ID: 37985224
[TBL] [Abstract][Full Text] [Related]
12. IGF2BP2 acts as a m
Tang X; Tang Q; Li S; Li M; Yang T
Cell Death Discov; 2023 Oct; 9(1):371. PubMed ID: 37816718
[TBL] [Abstract][Full Text] [Related]
13. m
Zhao Y; Zhou Y; Qian Y; Wei W; Lin X; Mao S; Sun J; Jin J
Clin Transl Med; 2024 Apr; 14(4):e1628. PubMed ID: 38572589
[TBL] [Abstract][Full Text] [Related]
14. FBW7/GSK3β mediated degradation of IGF2BP2 inhibits IGF2BP2-SLC7A5 positive feedback loop and radioresistance in lung cancer.
Zhou Z; Zhang B; Deng Y; Deng S; Li J; Wei W; Wang Y; Wang J; Feng Z; Che M; Yang X; Meng J; Li Y; Hu Y; Sun Y; Wen L; Huang F; Sheng Y; Wan C; Yang K
J Exp Clin Cancer Res; 2024 Jan; 43(1):34. PubMed ID: 38281999
[TBL] [Abstract][Full Text] [Related]
15. Anticancer role of lidocaine in oral squamous cell carcinoma through IGF2BP2-mediated CAV1 stability.
Wang Z; Zhang L; Wu T; Pan X; Li L; Liu Y
Oral Dis; 2023 Dec; ():. PubMed ID: 38071190
[TBL] [Abstract][Full Text] [Related]
16. IGF2BP2 promotes head and neck squamous carcinoma cell proliferation and growth via the miR-98-5p/PI3K/Akt signaling pathway.
Yu D; Xiao Z; Zou Z; Lin L; Li J; Tan J; Chen W
Front Oncol; 2023; 13():1252999. PubMed ID: 37936610
[TBL] [Abstract][Full Text] [Related]
17. Inhibin A contributes to the tumorigenesis of oral squamous cell carcinoma by KIAA1429-mediated m6A modification.
Chen X; Fan R
J Oral Pathol Med; 2024 Apr; 53(4):266-274. PubMed ID: 38531807
[TBL] [Abstract][Full Text] [Related]
18. IL-36 antagonism blunts the proliferation and migration of oral squamous cell carcinoma cells.
Li Z; Zhang X; Li K; Li F; Kou J; Wang Y; Wei X; Sun Y; Jing Y; Song Y; Yu Q; Yu H; Wang S; Chen S; Wang Y; Xie S; Zhu X; Zhan Y; Sun G; Ni Y
Cell Signal; 2024 May; 117():111096. PubMed ID: 38346528
[TBL] [Abstract][Full Text] [Related]
19. IGF2BP2 Drives Cell Cycle Progression in Triple-Negative Breast Cancer by Recruiting EIF4A1 to Promote the m6A-Modified CDK6 Translation Initiation Process.
Xia T; Dai XY; Sang MY; Zhang X; Xu F; Wu J; Shi L; Wei JF; Ding Q
Adv Sci (Weinh); 2024 Jan; 11(1):e2305142. PubMed ID: 37983610
[TBL] [Abstract][Full Text] [Related]
20. HNRNPA2B1 promotes oral squamous cell carcinogenesis via m
Wang X; Zhi M; Zhao W; Deng J
IUBMB Life; 2024 Jan; ():. PubMed ID: 38265150
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
